https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/accrued-insurance-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/accrued-royalties-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/accumulated-depreciation https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/additional-paid-in-capital https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/adjustment-for-amortization https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/aoci https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/assets-held-in-trust-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/assets-held-in-trust-noncurrent https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/bank-overdrafts https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/capital-expenditures https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/cash https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/cash-and-equivalents https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/cash-fdic-insured-amount https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/cash-flow-breakdown https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/common-stock-convertible-conversion-price-decrease https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/common-stock-value https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/comprehensive-income https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/contract-with-customer-asset-purchase https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/convertible-debt https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/current-assets https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/current-liabilities https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/debt-face-amount https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/deferred-compensation-arrangement-with-individual-compensation-expense https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/deferred-offering-costs https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/depreciation https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/due-to-related-parties-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/effective-tax-rate https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/equity-method-investment-aggregate-cost https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/financing-cash-flow https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/form-d-other https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/gain-loss-on-sale-of-investments https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/general-and-administrative-expense https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/income-taxes-paid https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/increase-decrease-in-prepaid-expenses-other https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/insider-transactions-other https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/insider-transactions-other/purchases https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/insider-transactions-warrants https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/interest-expense-related-party https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/interest-income-expense-net https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/interest-income-other https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/investing-cash-flow https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/investment-company-shareholder-service-fee-expense https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/investment-income-net https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/investment-owned-balance-principal-amount https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/line-of-credit https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/net-change-in-cash https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/net-income https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/noncurrent-assets https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/noninterest-expense-directors-fees https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/oci-before-tax https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/oci-foreign-currency-transaction-and-translation-adjustment-before-tax https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/officers-compensation https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/operating-cash-flow https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/operating-expenses https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/operating-income https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/operating-lease-payments-due https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/other-general-and-administrative-expense https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/other-noncurrent-assets https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/other-underwriting-expense https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/payment-for-administrative-fees https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/payments-for-purchase-of-other-assets https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/payments-for-underwriting-expense https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/payments-to-invest-in-decommissioning-fund https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/preferred-shares-facts https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/prepaid-expense-current https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/prepaid-expense-noncurrent https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/prepaid-insurance https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/prepaid-rent https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/pretax-income https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/proceeds-from-other-equity https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/proceeds-from-repayments-of-bank-overdrafts https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/proceeds-from-repayments-of-other-debt https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/profit-loss https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/property-plant-equipment https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/public-float https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/repayments-of-debt https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/research-and-development https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/retail-land-sales-deposit-method-deposit-received https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/retained-earnings https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/share-price https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/shareholders-equity https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/shares-authorized https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/shares-issued https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/shares-subject-to-mandatory-redemption-settlement-terms-number-of-shares https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/short-term-borrowings https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/shortterm-debt-average-outstanding-amount https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/sponsor-fees https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/stock-based-compensation https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/stock-redeemed-or-called-value https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/tax-reconciliation-nondeductible-expense-meals-and-entertainment https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/tax-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/tax-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/total-assets https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/total-liabilities https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/xynomic-pharmaceuticals-holdings-inc/weighted-average-number-of-share-outstanding-basic-and-diluted